Success Metrics

Active Trials

2(50%)

Phase Distribution

Ph not_applicable

75%

Ph phase_1

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution4 total trials

Phase 1Safety & dosage

1(25.0%)

N/ANon-phased studies

3(75.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(4)

Detailed Status

Not yet recruiting2

Active, not recruiting1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 1

Trials by Phase

Phase 11 (25.0%)

N/A3 (75.0%)

Trials by Status

active_not_recruiting125%

not_yet_recruiting250%

recruiting125%

Recent Activity

2 active trials

Showing 4 of 4

recruitingphase_1

Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)

NCT07361107

active_not_recruitingnot_applicable

Histotripsy (HistoSonics®) for Liver Tumours

NCT06579833

not_yet_recruitingnot_applicable

To Evaluate the Safety and Efficacy of Histotripsy for the Symptom Relief of Inoperable Abdominal Tumors

NCT07180706

not_yet_recruitingnot_applicable

Safety and Clinical Efficacy of Histotripsy for Liver Cancers Adjacent to Major Intrahepatic Vessels

NCT07063771

Clinical Trials (4)

Showing 4 of 4 trials

NCT07361107Phase 1

Evaluation of Circulating Immune Response After Histosonics in Colorectal Cancer (ECHO-CRC)

Recruiting

NCT06579833Not Applicable

Histotripsy (HistoSonics®) for Liver Tumours

Active Not Recruiting

NCT07180706Not Applicable

To Evaluate the Safety and Efficacy of Histotripsy for the Symptom Relief of Inoperable Abdominal Tumors

Not Yet Recruiting

NCT07063771Not Applicable

Safety and Clinical Efficacy of Histotripsy for Liver Cancers Adjacent to Major Intrahepatic Vessels

Not Yet Recruiting

All 4 trials loaded

Drug Details

Intervention Type: PROCEDURE
Total Trials: 4